psychedelics investing Lobe Sciences Advances Governance and Capital Markets Expertise with Appointment of Mr. Nick Karakochuk to the Board of Directors
psychedelics investing Lobe Sciences Reports FY2025 with a Stronger Balance Sheet and Sharpened Strategy
psychedelics investing Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
psychedelics investing Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto
psychedelics investing Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Additional Details Regarding the Acquisition of Altemia & Company
psychedelics investing Lobe Sciences Announces Commercial Distribution Agreement With Pentec Health for US Launch of Altemia
Copper Quest Announces Fully Subscribed Private Placement with Continued Support by Strategic International Investor
LaFleur Minerals Appoints Andrew Elinesky as Chief Executive Officer and Provides Update on Beacon Gold Mill Recommissioning Work and Swanson Bulk Sample Progress
